曾泽贤
电子邮件: zexianzeng@pku(dot)edu(dot)cn
实验室主页:http://cqb.pku.edu.cn/zenglab/
研究方向:
聚焦肿瘤免疫学,有机结合数据挖掘与生物技术,研究肿瘤免疫调控机制与免疫细胞互作,揭示肿瘤免疫反应机理,旨在为临床免疫治疗成功率的提高提供新的靶向基因,为免疫调控基因的发现提供新的研究思路,为临床肿瘤用药提供新的方法。
代表性科研论文:
1. Zeng Z*, Gu S*, Wong C, Li D, Lin Y, Wong C, Ouardaoui N, Zhang W, Brown M, Liu XS: A joint dimension reduction framework to model immunotherapy response for syngeneic mouse models. Science Advances (2022) 10.1126
2. Zeng Z*, Gu S*, Yang L, Wong C, Ouardaoui N, Zhang W, Li D, Weirather J, Zhang Y, Meyer C, Rodig S, Hodi SF#, Brown M#, Liu XS#: Hippo signaling pathway regulates MHCII expression in melanoma. Cancer Immunology Research (2022) 10.1158
3. Zeng Z*,#, Wong C*, Lin Y*, Li D, Zhang Y, Gu S, Zhang W, Kim S, Yates K, Freeman G, Brown M, Manguso R, Liu XS#: TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Research (2021) 10.1093
4. Zeng Z*, Li Y*, Li Yi*, Luo Y: Computational methods for spatially resolved transcriptomics data analysis. Genome Biology (2022) 10.02653
5. Zeng Z*, Fu J*, Cibulskis C, Jhaveri A, Gumbs C, Das B, … & Liu XS#, Wu C#: Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms for the CIMAC-CIDC network. Clinical Cancer Research. (2021).20.3251
6. Kumar S*, Zeng Z*, Bagati A*, Tay Re*, Sanz L, Hartono SR, … & Liu XS#, Wucherpfennig K#: Carm1 inhibition enables immunotherapy of resistant tumors by dual action on tumor and T-cells. Cancer Discovery (2021). 20-1144
7. Zhou L*, Zeng Z*, Egloff A, Zhang F, Guo F, Cambell K, Du P, … & Liu XS#, Uppaluri R#: Checkpoint blockade induced CD8+ T cell differentiation in responders in head and neck cancers. Journal for ImmunoTherapy of Cancer (2021). 10 (1), e004034
8. Zeng Z, Vo A, Li X, Shidfar Ali, Saldana P, Xuei X, Luo Y, Khan AS, Clare SE: Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer. npj Breast Cancer. (2020). 6(1),1-11
9. Zeng Z, Amin A, Roy A, Pulliam N, Karavites L, Espino S, Li X, Luo Y, Khan AS: Preoperative magnetic resonance imaging and oncologic outcomes in premenopausal breast cancer patients. npj Breast Cancer. (2020). 6(1),1-8.
10. Zeng Z, Vo A, Mao C, Clare S, Khan S, Luo Y: Cancer classification and pathway discovering using non-negative matrix factorization. Journal of Biomedical Informatics. (2019): 103247